Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-13 5:51 pm Sale |
2022-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR |
BIOTECHNOLOGY VALUE FUND L P | 75,280 1.900% |
-25,642 (-25.41%) |
Filing History |
| 2023-01-13 08:02 am Purchase |
2022-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR |
Empery Asset Management, LP | 206,623 5.120% |
206,623 (New Position) |
Filing History |
| 2022-12-19 5:31 pm Purchase |
2022-12-09 | 13D | X4 Pharmaceuticals, Inc. XFOR |
Growth Equity Opportunities 18 VGE LLC | 404,560 9.990% |
175,288 (+76.45%) |
Filing History |
| 2022-07-19 5:28 pm Purchase |
2022-07-06 | 13D | X4 Pharmaceuticals, Inc. XFOR |
Growth Equity Opportunities 18 VGE LLC | 229,272 9.900% |
229,272 (New Position) |
Filing History |
| 2022-02-14 4:43 pm Sale |
2021-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR |
Ikarian Capital LLC | 75,483 8.100% |
-12,017 (-13.73%) |
Filing History |
| 2022-02-14 4:38 pm Purchase |
2021-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR |
Point72 Asset Management, L.P. | 54,440 5.800% |
4,432 (+8.86%) |
Filing History |
| 2022-02-14 4:11 pm Sale |
2021-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR |
RA Capital Management, L.P. | 37,867 3.900% |
-20,401 (-35.01%) |
Filing History |
| 2022-02-14 1:02 pm Purchase |
2021-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR |
BIOTECHNOLOGY VALUE FUND L P | 100,922 9.990% |
43,602 (+76.07%) |
Filing History |
| 2022-02-14 06:39 am Purchase |
2021-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR |
BCLS I Investco, LP | 96,218 11.000% |
41,269 (+75.10%) |
Filing History |
| 2022-02-11 5:08 pm Purchase |
2021-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR |
ORBIMED ADVISORS LLC | 61,212 6.400% |
12 (+0.02%) |
Filing History |
| 2022-02-11 3:17 pm Purchase |
2021-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR |
Orin Hirschman | 51,053 6.200% |
2,423 (+4.98%) |
Filing History |
| 2022-01-19 11:05 am Purchase |
2022-01-14 | 13G | X4 Pharmaceuticals, Inc. XFOR |
Lincoln Park Capital Fund LLC | 60,336 6.440% |
60,336 (New Position) |
Filing History |
| 2021-11-17 5:27 pm Purchase |
2021-11-09 | 13G | X4 Pharmaceuticals, Inc. XFOR |
Point72 Asset Management, L.P. | 50,008 5.600% |
50,008 (New Position) |
Filing History |
| 2021-06-28 7:32 pm Purchase |
2021-06-16 | 13G | X4 Pharmaceuticals, Inc. XFOR |
Orin Hirschman | 48,630 6.200% |
48,630 (New Position) |
Filing History |
| 2021-05-07 5:09 pm Purchase |
2021-04-30 | 13G | X4 Pharmaceuticals, Inc. XFOR |
BlackRock Inc. BLK |
35,816 4.500% |
1,366 (+3.97%) |
Filing History |
| 2021-04-08 09:02 am Purchase |
2021-03-23 | 13G | X4 Pharmaceuticals, Inc. XFOR |
Ikarian Capital LLC | 87,500 11.100% |
59,952 (+217.63%) |
Filing History |
| 2021-03-25 4:15 pm Purchase |
2021-03-23 | 13G | X4 Pharmaceuticals, Inc. XFOR |
ORBIMED ADVISORS LLC | 61,200 7.600% |
19,567 (+47.00%) |
Filing History |
| 2021-02-16 4:39 pm Purchase |
2020-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR |
RA Capital Management, L.P. | 58,267 9.900% |
3,318 (+6.04%) |
Filing History |
| 2021-02-16 08:55 am Purchase |
2020-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR |
SPHERA FUNDS MANAGEMENT LTD. | 8,333 1.510% |
8,333 (New Position) |
Filing History |
| 2021-02-12 8:57 pm Purchase |
2020-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR |
BIOTECHNOLOGY VALUE FUND L P | 57,321 9.990% |
1,971 (+3.56%) |
Filing History |